DYN
Dyne Therapeutics, Inc
$24.87
Earnings Summary
Revenue | $3.79Mn |
Net Profits | $-66.64Mn |
Net Profit Margins | -1759.19% |
Highlights
Dyne Therapeutics, Inc’s revenue jumped +Inf% since last year same period to $3.79Mn in the Q4 2023. On a quarterly growth basis, Dyne Therapeutics, Inc has generated +Inf% jump in its revenue since last 3-months.
Dyne Therapeutics, Inc’s net profit fell -77.65% since last year same period to $-66.64Mn in the Q4 2023. On a quarterly growth basis, Dyne Therapeutics, Inc has generated -10.68% fall in its net profits since last 3-months.
Dyne Therapeutics, Inc’s net profit margin jumped NaN% since last year same period to -1759.19% in the Q4 2023. On a quarterly growth basis, Dyne Therapeutics, Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Dyne Therapeutics, Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.8 |
EPS Estimate Current Year | -0.8 |
Highlights
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.8 - a 13.04% jump from last quarter’s estimates.
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.8.
Key Ratios
Key ratios of the Dyne Therapeutics, Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -1.09 |
Highlights
Dyne Therapeutics, Inc’s earning per share (EPS) fell -47.3% since last year same period to -1.09 in the Q4 2023. This indicates that the Dyne Therapeutics, Inc has generated -47.3% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-10-30 | -0.83 | -0.99 | -19.28% |
2023-05-11 | -0.77 | -0.78 | -1.3% |
2023-08-03 | -0.81 | -1.08 | -33.33% |
2024-03-05 | -0.92 | -1.09 | -18.48% |
₹0 US Stocks a/c Opening Fee